

The ER/PR Assay (Breast Cancer) detects estrogen and progesterone receptors in breast tumors to help guide treatment, assess prognosis, and predict response to hormone therapy. Patients with ER-positive and/or PR-positive tumors are more likely to benefit from treatments such as Tamoxifen.
Other Name: Estrogen Receptor Assay (ER), Progesterone Receptor Assay (PR)
No patient preparation is required for this service
Unit 102, Del Rio 2 Building, San Agustin Drive cor. BS Aquino Drive, Brgy. 5, Bacolod City
Add more services to your booking and save on multiple visits






